Lars Henning Engelholm

Lars Henning Engelholm

ORCID: 0000-0002-6616-1232

Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2012
  2. Published

    Plasmin-driven fibrinolysis facilitates skin tumor growth in a gender-dependent manner

    Hald, A., Eickhardt, H., Maerkedahl, R. B., Feldborg, C. W., Egerod, Kristoffer Lihme, Engelholm, Lars Henning, Laerum, O. D., Lund, L. R. & Rønø, B., Nov 2012, In: F A S E B Journal. 26, 11, p. 4445-4457 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo

    Lund, I. K., Rasch, M. G., Ingvarsen, S., Pass, J., Madsen, Daniel Hargbøl, Engelholm, Lars Henning, Behrendt, Niels & Høyer-Hansen, G., 2012, In: Frontiers in Pharmacology. 3, p. 122

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    No Effect of NGAL/lipocalin-2 on Aggressiveness of Cancer in the MMTV-PyMT/FVB/N Mouse Model for Breast Cancer

    Cramer, E. P., Glenthøj, Andreas Birkedal, Häger, M., Juncker-Jensen, A., Engelholm, Lars Henning, Santoni Rugiu, Eric, Lund, L. R., Laerum, O. D., Cowland, J. B. & Borregaard, N., 2012, In: P L o S One. 7, 6, p. e39646

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 9647887